Literature DB >> 324771

Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.

B G Hansson, J F Dymling, H Hedeland, U L Hulthén.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 324771     DOI： 10.1007/bf00607671

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  34 in total

1.  Blood volume determinations with the Evans blue dye method; an experimental and clinical investigation with special reference to the blood volume in pulmonary tuberculosis.

Authors:  B T D VON PORAT
Journal:  Acta Med Scand Suppl       Date:  1951

2.  The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.

Authors:  M D Day; A G Roach
Journal:  Clin Sci Mol Med Suppl       Date:  1975-06

3.  Effect of beta-adrenergic blockade on plasma volume in human subjects.

Authors:  S Julius; A V Pascual; P H Abbrecht; R London
Journal:  Proc Soc Exp Biol Med       Date:  1972-07

4.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

5.  Effect of practolol on blood pressure and renin release in man.

Authors:  M D Esler
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

6.  A sensitive double-isotope derivative assay for norepinephrine and epinephrine. Normal resting human plasma levels.

Authors:  K Engelman; B Portnoy
Journal:  Circ Res       Date:  1970-01       Impact factor: 17.367

7.  Central hypotensive activity of dl- and d-propranolol.

Authors:  G J Kelliher; J P Buckley
Journal:  J Pharm Sci       Date:  1970-09       Impact factor: 3.534

8.  Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness.

Authors:  M D Esler; P J Nestel
Journal:  Br Heart J       Date:  1973-05

9.  Comparison of the effects of propranolol and ICI 66082 in blocking the renin releasing effect of renal nerve stimulation in the cat.

Authors:  E J Johns; B Singer
Journal:  Br J Pharmacol       Date:  1974-10       Impact factor: 8.739

10.  Controlled study of atenolol in treatment of hypertension.

Authors:  L Hansson; H Aberg; B E Karlberg; A Westerlund
Journal:  Br Med J       Date:  1975-05-17
View more
  17 in total

Review 1.  Influence of antihypertensive drugs on exercise capacity.

Authors:  R Fagard; J Staessen; L Thijs; A Amery
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 2.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

Review 3.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

4.  Influence of metoprolol, alone and in combination with a thiazide diuretic, on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension.

Authors:  S Rasmussen; K Rasmussen
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

5.  Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.

Authors:  B G Hansson; J F Dymling; P Manhem; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

6.  Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

7.  Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise.

Authors:  G Planz; R Planz
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

Review 8.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

9.  Exercise haemodynamics and maximal exercise capacity during beta-adrenoceptor blockade in normotensive and hypertensive subjects.

Authors:  M A van Baak; F M Koene; F T Verstappen
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

Review 10.  Exercise performance and beta-blockade.

Authors:  P A Tesch
Journal:  Sports Med       Date:  1985 Nov-Dec       Impact factor: 11.136
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.